Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →Centum Electronics reported a strong Q4 FY26 with standalone revenue of ₹344 crore (+26% YoY) and EBITDA of ₹46 crore (+5% YoY, margin 13.22%).
✓ Verified against BSE filing
Centum Electronics reported a strong Q4 FY26 with standalone revenue of ₹344 crore (+26% YoY) and EBITDA of ₹46 crore (+5% YoY, margin 13.22%). Full-year standalone revenue hit a record ₹973 crore (+25% YoY) with EBITDA of ₹121 crore (+28% YoY, margin 12.42%). Growth was driven by robust execution in BTS (+37% YoY) and EMS (+21% YoY), supported by a record order book of ₹1,645 crore (+23% YoY). Key wins include a ₹570 crore AESA radar program from HAL and a second radar system order. Management guided for 25-30% medium-term revenue growth and 13-15% EBITDA margins, with overseas restructuring on track for deconsolidation by Q2 FY27. Risk: supply chain constraints on copper clad laminates and memory components could pressure EMS margins.
सेंटम इलेक्ट्रॉनिक्स ने वित्त वर्ष 2026 की चौथी तिमाही में शानदार प्रदर्शन किया। कंपनी की कमाई 344 करोड़ रुपये रही, जो पिछले साल से 26% ज्यादा है। कमाई में से मुनाफा (EBITDA) 46 करोड़ रुपये रहा, जो 5% बढ़ा और मार्जिन 13.22% रहा। पूरे साल की कमाई 973 करोड़ रुपये के रिकॉर्ड स्तर पर पहुंच गई, जो 25% ज्यादा है। मुनाफा 121 करोड़ रुपये रहा, जो 28% बढ़ा। कंपनी को HAL से 570 करोड़ रुपये का रडार प्रोजेक्ट मिला है। आने वाले समय में कमाई 25-30% और मुनाफा 13-15% बढ़ने की उम्मीद है। हालांकि, कच्चे माल की कमी से मार्जिन पर दबाव पड़ सकता है।
0 delivered, 0 close, 3 missed.
View Promises →Supply chain constraints on key components
View Risks →Full transcript text is available on this route.
Read Transcript →Order book provides strong revenue visibility for coming years.
Build-to-spec business driven by defense, space, and radar programs.
Marquee program for UHM platform; development phase of ~₹65 crore underway.
Improved from 12.40% reflecting stronger profitability and capital efficiency.
Management targets 25-30% revenue growth on a medium-term basis at standalone level, driven by defense, aerospace, and semiconductor tailwinds.
Management expects EBITDA margins to improve to 13-15% over the next 1-2 years, aided by better product mix and operating leverage.
Capital expenditure for FY27 is expected to be in the range of ₹40-45 crore, with ~50% allocated to BTS R&D capabilities.
Management expects the French subsidiary to be deconsolidated by Q1 or Q2 FY27, with no further exceptional losses expected.
Management expects to receive the order for the ₹700 crore radar system in Q4 FY26.
Revenue from the new semiconductor equipment customer is expected to grow from $10 million in FY26 to $30 million annual run-rate within two years.
Management expects to maintain or improve standalone EBITDA margins in Q4 FY26, driven by operating leverage and higher revenue.
Clarity on French subsidiary divestment or judicial reorganization expected by Q4 FY26 reporting.
Copper clad laminate and memory component lead times are increasing due to global demand, potentially impacting EMS execution.
FY26 EBITDA margin of 12.42% was below the guided 13-15% range due to unfavorable EMS product mix; improvement depends on mix shift.
BTS order inflow in FY26 was only ~₹470 crore (low growth), with some orders slipping to FY27; execution visibility depends on timely closures.
Management confirmed no expected realization from the French asset sale; liabilities exceed assets by over ₹100 crore.
Until deconsolidation, operating losses from French subsidiary will continue to impact consolidated financials.
BTS revenues are tied to major program deliveries, leading to quarter-on-quarter volatility.
Management expects minimal cash recovery from Canadian subsidiary after winding up.
Prolonged weak macro environment in Europe and subdued demand in R&D services market affected turnaround efforts.
Management targets 25-30% revenue growth on a medium-term basis at standalone level, driven by defense, aerospace, and semiconductor tailwinds.
Copper clad laminate and memory component lead times are increasing due to global demand, potentially impacting EMS execution.
View Risks →